S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
NASDAQ:MARK

Remark Stock Forecast, Price & News

$1.51
+0.05 (+3.42 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.48
Now: $1.51▼
$1.62
50-Day Range
$1.04
MA: $1.23▼
$1.59
52-Week Range
$0.25
Now: $1.51▼
$3.56
Volume4.65 million shs
Average Volume12.80 million shs
Market Capitalization$150.25 million
P/E RatioN/A
Dividend YieldN/A
Beta3.16
Remark Holdings, Inc., technology-focused company, develops and deploys artificial intelligence (AI) products and AI-based solutions for businesses in various industries worldwide. The company operates KanKan, a data intelligence platform that offers AI-based vision products, computing devices, and software-as-a-service products for the retail, life cycle, and workplace and food safety industries. It also owns and operates Sharecare, a web-based platform that facilitates search for health and wellness information; and Bikini.com, an e-commerce website, which sells swimwear and accessories. The company was formerly known as Remark Media, Inc. and changed its name to Remark Holdings, Inc. in April 2017. Remark Holdings, Inc. was founded in 2006 and is headquartered in Las Vegas, Nevada.
Remark logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.22 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Communication services, not elsewhere classified
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:MARK
Previous Symbol
CUSIPN/A
CIK1368365
Webwww.remarkholdings.com
Phone702-701-9514
Employees290

Debt

Debt-to-Equity RatioN/A
Current Ratio0.67
Quick Ratio0.80

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.02 million
Price / Sales29.93
Cash FlowN/A
Price / Cash FlowN/A
Book Value($0.03) per share
Price / Book-50.33

Profitability

EPS (Most Recent Fiscal Year)($0.52)
Net Income$-25,610,000.00
Net Margins-299.36%
Return on EquityN/A
Return on Assets-110.49%

Miscellaneous

Outstanding Shares99,502,000
Market Cap$150.25 million
Next Earnings Date5/27/2021 (Estimated)
OptionableOptionable
$1.51
+0.05 (+3.42 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MARK News and Ratings via Email

Sign-up to receive the latest news and ratings for MARK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Remark (NASDAQ:MARK) Frequently Asked Questions

How has Remark's stock been impacted by Coronavirus?

Remark's stock was trading at $0.45 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MARK shares have increased by 235.6% and is now trading at $1.51.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Remark?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Remark in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Remark or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Remark?

Wall Street analysts have given Remark a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Remark wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Remark's next earnings date?

Remark is scheduled to release its next quarterly earnings announcement on Thursday, May 27th 2021.
View our earnings forecast for Remark.

How were Remark's earnings last quarter?

Remark Holdings, Inc. (NASDAQ:MARK) announced its quarterly earnings data on Sunday, November, 22nd. The information services provider reported $0.04 EPS for the quarter, topping the Zacks' consensus estimate of ($0.04) by $0.08.
View Remark's earnings history.

What guidance has Remark issued on next quarter's earnings?

Remark issued an update on its third quarter 2020 After-Hours earnings guidance on Monday, November, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.5-2.7 million, compared to the consensus revenue estimate of $2.82 million.

What price target have analysts set for MARK?

1 analysts have issued twelve-month target prices for Remark's shares. Their forecasts range from $4.25 to $4.25. On average, they expect Remark's stock price to reach $4.25 in the next twelve months. This suggests a possible upside of 181.5% from the stock's current price.
View analysts' price targets for Remark.

Are investors shorting Remark?

Remark saw a increase in short interest during the month of October. As of October 30th, there was short interest totaling 11,030,000 shares, an increase of 21.2% from the October 15th total of 9,100,000 shares. Based on an average daily volume of 4,300,000 shares, the days-to-cover ratio is currently 2.6 days.
View Remark's Short Interest.

Who are some of Remark's key competitors?

Some companies that are related to Remark include Globalstar (GSAT), Globalstar (GSAT), ORBCOMM (ORBC), uCloudlink Group (UCL), Ayro (AYRO), RigNet (RNET), B Communications (BCOMF), Intelsat (INTEQ), Lithium (LTUM), Global Eagle Entertainment (GEENQ), Plaintree Systems (PTEEF), Towerstream (TWER), DirectView (DIRV), Radioio (RAIO) and China Teletech (CNCT).
View all competitors.

What other stocks do shareholders of Remark own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Remark investors own include Sorrento Therapeutics (SRNE), ADMA Biologics (ADMA), Heat Biologics (HTBX), OrganiGram (OGI), Genius Brands International (GNUS), Matinas BioPharma (MTNB), Vaxart (VXRT), Bionano Genomics (BNGO), Tilly's (TLYS) and Novan (NOVN).

Who are Remark's key executives?

Remark's management team includes the following people:
  • Mr. Kai-Shing Tao, Chairman & CEO (Age 43, Pay $350k)
  • Mr. E. Brian Harvey, Sr. VP of Capital Markets & Investor Relations
  • Mr. Wei Zhou, Pres & CEO of INTAC (Age 41)

What is Remark's stock symbol?

Remark trades on the NASDAQ under the ticker symbol "MARK."

Who are Remark's major shareholders?

Remark's stock is owned by many different institutional and retail investors. Top institutional shareholders include Cutter & CO Brokerage Inc. (1.67%), Cannell Peter B & Co. Inc. (0.54%), BlackRock Inc. (0.38%), SG Americas Securities LLC (0.24%), Central Bank & Trust Co. (0.16%) and Morgan Stanley (0.14%).
View institutional ownership trends for Remark.

Which major investors are buying Remark stock?

MARK stock was acquired by a variety of institutional investors in the last quarter, including Cutter & CO Brokerage Inc., SG Americas Securities LLC, Central Bank & Trust Co., BlackRock Inc., Cannell Peter B & Co. Inc., Morgan Stanley, Squarepoint Ops LLC, and Cypress Capital Management LLC WY.
View insider buying and selling activity for Remark.

How do I buy shares of Remark?

Shares of MARK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Remark's stock price today?

One share of MARK stock can currently be purchased for approximately $1.51.

How big of a company is Remark?

Remark has a market capitalization of $150.25 million and generates $5.02 million in revenue each year. The information services provider earns $-25,610,000.00 in net income (profit) each year or ($0.52) on an earnings per share basis. Remark employs 290 workers across the globe.

What is Remark's official website?

The official website for Remark is www.remarkholdings.com.

How can I contact Remark?

Remark's mailing address is 800 S COMMERCE ST, LAS VEGAS NV, 89106. The information services provider can be reached via phone at 702-701-9514 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.